Related references
Note: Only part of the references are listed.Immune Regulatory Function of B Cells
Claudia Mauri et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
Aharon Kessel et al.
AUTOIMMUNITY REVIEWS (2012)
High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcγ receptors on monocytes in patients with primary immune thrombocytopenia
Xin-guang Liu et al.
BLOOD (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2011)
Mice Lacking Endogenous IL-10-Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells
Natalie A. Carter et al.
JOURNAL OF IMMUNOLOGY (2011)
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
Weili Bao et al.
BLOOD (2010)
IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro
Jean-David Bouaziz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model
Sylvie Amu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Identification of a B cell signature associated with renal transplant tolerance in humans
Kenneth A. Newell et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia
Xiao-juan Zhu et al.
BLOOD (2009)
Chronic Idiopathic Thrombocytopenic Purpura: Mechanisms of Pathogenesis
Terry Gernsheimer
ONCOLOGIST (2009)
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab
Roberto Stasi et al.
BLOOD (2008)
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
Jin Yu et al.
BLOOD (2008)
Memory B cells and pneumococcal antibody after splenectomy
Heather Wasserstrom et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Response to B-cell-depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
Roberto Stasi et al.
BLOOD (2007)
Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome
Yun Ling et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Reduced Cd4(+)Cd25(+) T cells in patients with idiopathic thrombocytopenic purpura
Miho Sakakura et al.
THROMBOSIS RESEARCH (2007)
High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura
Florian Emmerich et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Platelet-associated CD154 in immune thrombocytopenic purpura
A Solanilla et al.
BLOOD (2005)
High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura
H Ogawara et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
T cell receptor VB repertoire diversity in patients with immune thrombocytopenia following splenectomy
PF Fogarty et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Engagement of glycoprotein IIb/IIIa (αIIbβ3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells
AE May et al.
CIRCULATION (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease
K Warnatz et al.
BLOOD (2002)
Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome
JO Bohnhorst et al.
JOURNAL OF IMMUNOLOGY (2001)
Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus
E Arce et al.
JOURNAL OF IMMUNOLOGY (2001)
Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura
M Kuwana et al.
BLOOD (2001)
B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation
V Moulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)